A Clinician's Guide to X-Linked Hypophosphatemia

被引:464
作者
Carpenter, Thomas O. [1 ,2 ]
Imel, Erik A. [3 ,4 ]
Holm, Ingrid A. [5 ,6 ,7 ]
de Beur, Suzanne M. Jan [8 ]
Insogna, Karl L. [9 ]
机构
[1] Yale Univ, Sch Med, Dept Pediat Endocrinol, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Dept Orthopaed & Rehabil, New Haven, CT 06520 USA
[3] Indiana Univ Sch Med, Dept Med, Indianapolis, IN USA
[4] Indiana Univ Sch Med, Dept Pediat Endocrinol, Indianapolis, IN USA
[5] Childrens Hosp, Program Genom, Div Genet, Boston, MA 02115 USA
[6] Childrens Hosp, Manton Ctr Orphan Dis Res, Boston, MA 02115 USA
[7] Harvard Univ, Sch Med, Boston, MA USA
[8] Johns Hopkins Sch Med, Dept Med, Div Endocrinol, Baltimore, MD USA
[9] Yale Univ, Sch Med, Dept Internal Med Endocrinol, New Haven, CT USA
关键词
PHOSPHATE; FGF23; PHEX; RICKETS; OSTEOMALACIA; GROWTH-HORMONE TREATMENT; LONG-TERM TREATMENT; MINERAL METABOLISM; PHOSPHATE HOMEOSTASIS; RICKETS; CALCITRIOL; THERAPY; MUTATIONS; CHILDREN; GENE;
D O I
10.1002/jbmr.340
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
X-linked hypophosphatemia (XLH) is the prototypic disorder of renal phosphate wasting, and the most common form of heritable rickets. Physicians, patients, and support groups have all expressed concerns about the dearth of information about this disease and the lack of treatment guidelines, which frequently lead to missed diagnoses or mismanagement. This perspective addresses the recommendation by conferees for the dissemination of concise and accessible treatment guidelines for clinicians arising from the Advances in Rare Bone Diseases Scientific Conference held at the NIH in October 2008. We briefly review the clinical and pathophysiologic features of the disorder and offer this guide in response to the conference recommendation, based on our collective accumulated experience in the management of this complex disorder. (C) 2011 American Society for Bone and Mineral Research.
引用
收藏
页码:1381 / 1388
页数:8
相关论文
共 44 条
[41]   Klotho converts canonical FGF receptor into a specific receptor for FGF23 [J].
Urakawa, Itaru ;
Yamazaki, Yuji ;
Shimada, Takashi ;
Iijima, Kousuke ;
Hasegawa, Hisashi ;
Okawa, Katsuya ;
Fujita, Toshiro ;
Fukumoto, Seiji ;
Yamashita, Takeyoshi .
NATURE, 2006, 444 (7120) :770-774
[42]   EFFECTS OF THERAPY IN X-LINKED HYPOPHOSPHATEMIC RICKETS [J].
VERGE, CF ;
LAM, A ;
SIMPSON, JM ;
COWELL, CT ;
HOWARD, NJ ;
SILINK, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (26) :1843-1848
[43]   Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23 [J].
White, KE ;
Evans, WE ;
O'Riordan, JLH ;
Speer, MC ;
Econs, MJ ;
Lorenz-Depiereux, B ;
Grabowski, M ;
Meitinger, T ;
Strom, TM .
NATURE GENETICS, 2000, 26 (03) :345-348
[44]   GROWTH-HORMONE THERAPY IN HYPOPHOSPHATEMIC RICKETS [J].
WILSON, DM ;
LEE, PDK ;
MORRIS, AH ;
REITER, EO ;
GERTNER, JM ;
MARCUS, R ;
QUARMBY, VE ;
ROSENFELD, RG .
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1991, 145 (10) :1165-1170